OM

Omkarbhai Maheshkumar Dave

Active Director Designated Partner DIN 10510128
DIN 10510128 First appointment Feb 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Omkarbhai Maheshkumar Dave

Data last updated:

Omkarbhai Maheshkumar Dave is a Designated Partner at Critisure Meditech Llp (since 2024).

DIN 10510128
Primary Designation Designated Partner
First Appointment 16 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner16 Feb 20242024Active

Board colleagues of Omkarbhai Maheshkumar Dave

NameDINCompanyDesignation
Vipul Savdasbhai Bhatu10510127Critisure Meditech LlpDesignated Partner
Vishal Jagamalbhai Suva10510129Critisure Meditech LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Critisure Meditech Llp
Premium access

Shareholding and investment profile for Omkarbhai Maheshkumar Dave

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Omkarbhai Maheshkumar Dave

Omkarbhai Maheshkumar Dave currently holds 1 directorship: Critisure Meditech Llp (Designated Partner, since 16 Feb 2024).

Omkarbhai Maheshkumar Dave was first appointed on 16 Feb 2024 as Designated Partner at Critisure Meditech Llp.

The current boards of Omkarbhai Maheshkumar Dave's companies include Vipul Savdasbhai Bhatu (Critisure Meditech Llp), Vishal Jagamalbhai Suva (Critisure Meditech Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available